000760630 000__ 03421cam\a2200481Ii\4500
000760630 001__ 760630
000760630 005__ 20230306142117.0
000760630 006__ m\\\\\o\\d\\\\\\\\
000760630 007__ cr\cn\nnnunnun
000760630 008__ 140919s2014\\\\gw\a\\\\o\\\\\001\0\eng\d
000760630 019__ $$a908086253
000760630 020__ $$a9783662438367$$q(electronic book)
000760630 020__ $$a3662438364$$q(electronic book)
000760630 020__ $$z9783662438350
000760630 0247_ $$a10.1007/978-3-662-43836-7$$2doi
000760630 035__ $$aSP(OCoLC)ocn890932557
000760630 035__ $$aSP(OCoLC)890932557$$z(OCoLC)908086253
000760630 040__ $$aGW5XE$$beng$$erda$$epn$$cGW5XE$$dE7B$$dCOO$$dYDXCP$$dN$T$$dOCLCF$$dEBLCP$$dOCLCO$$dOCLCQ$$dOCLCO
000760630 049__ $$aISEA
000760630 050_4 $$aTP248.27.P55
000760630 08204 $$a660.6$$223
000760630 24500 $$aCommercial plant-produced recombinant protein products :$$bcase studies /$$cJohn A. Howard, Elizabeth E. Hood, editors.
000760630 264_1 $$aHeidelberg :$$bSpringer,$$c2014.
000760630 300__ $$a1 online resource (xii, 281 pages) :$$billustrations.
000760630 336__ $$atext$$btxt$$2rdacontent
000760630 337__ $$acomputer$$bc$$2rdamedia
000760630 338__ $$aonline resource$$bcr$$2rdacarrier
000760630 4901_ $$aBiotechnology in Agriculture and Forestry,$$x0934-943X ;$$vvolume 68
000760630 500__ $$aIncludes index.
000760630 5050_ $$aIntroduction? Plant-produced protein products -- Commercial Plant-Produced Recombinant Avidin -- Molecular farming in plants? the long road to the market -- TrypZeanTM: an animal-free alternative to bovine trypsin -- Production of Pharmaceutical Grade Recombinant Native Aprotinin and Non-Oxidized Aprotinin-Variants Under Greenhouse and Field Conditions -- Influenza virus-like particles produced in Nicotiana benthamiana protect against a lethal viral challenge in mice -- Plant-Produced Recombinant Transmission Blocking Vaccine Candidates to Combat Malaria -- An oral vaccine for TGEV immunization of pigs -- Edible Rabies Vaccines -- Newcastle disease vaccines -- An oral vaccine for hepatitis B: challenges, setbacks and breakthroughs -- Commercial Plant-Produced Recombinant Cellulases for Biomass Conversion -- Brazzein: A High Intensity Natural Sweetener -- The Future of Plant-Produced Pharmaceuticals and Industrial Proteins.
000760630 506__ $$aAccess limited to authorized users.
000760630 520__ $$aAttention has recently turned to using plants as hosts for the production of commercially important proteins. The twelve case studies in this volume present successful strategies for using plants to produce industrial and pharmaceutical proteins and vaccine antigens. They examine in detail projects that have commercial potential or products that have already been commercialized, illustrating the advantages that plants offer over bacterial, fungal or animal cell-culture hosts. There are many indications that plant protein production marks the beginning of a new paradigm for the commercial production of proteins that, over the next decade, will expand dramatically.
000760630 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed September 19, 2014).
000760630 650_0 $$aPlant proteins$$xBiotechnology.
000760630 650_0 $$aPlant biotechnology.
000760630 7001_ $$aHoward, John A.,$$eeditor.
000760630 7001_ $$aHood, Elizabeth E.,$$eeditor.
000760630 77608 $$iPrint version:$$z9783662438350
000760630 830_0 $$aBiotechnology in agriculture and forestry ;$$vv.68.
000760630 852__ $$bebk
000760630 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-662-43836-7$$zOnline Access$$91397441.1
000760630 909CO $$ooai:library.usi.edu:760630$$pGLOBAL_SET
000760630 980__ $$aEBOOK
000760630 980__ $$aBIB
000760630 982__ $$aEbook
000760630 983__ $$aOnline
000760630 994__ $$a92$$bISE